CIBC International Index Class F-Premium (CIB317)
16.94
-0.17
(-0.99%)
CAD |
Oct 07 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.50% | 1.845B | 2.76% | 3.53% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 172.24M | 20.46% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment objective of the Fund is to provide long-term growth through capital appreciation. The Fund is managed to obtain a return that approximates the performance of the MSCI EAFE Index. The MSCI EAFE Index is a free float-adjusted market capitalization index of stocks of companies of developed market equity indices covering 21 different countries in Europe, Australasia, and the Far East. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Equity |
| Global Macro | Equity Global |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | CIBC |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
9
-122.24M
Peer Group Low
498.40M
Peer Group High
1 Year
% Rank:
14
172.24M
-1.590B
Peer Group Low
3.808B
Peer Group High
3 Months
% Rank:
6
-154.79M
Peer Group Low
1.175B
Peer Group High
3 Years
% Rank:
16
-2.955B
Peer Group Low
5.720B
Peer Group High
6 Months
% Rank:
94
-1.133B
Peer Group Low
2.449B
Peer Group High
5 Years
% Rank:
3
-2.156B
Peer Group Low
7.630B
Peer Group High
YTD
% Rank:
87
-1.663B
Peer Group Low
3.415B
Peer Group High
10 Years
% Rank:
2
-1.537B
Peer Group Low
10.34B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of October 08, 2025.
Asset Allocation
As of August 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.24% |
| Stock | 97.82% |
| Bond | 1.53% |
| Convertible | 0.00% |
| Preferred | 0.32% |
| Other | 0.09% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| iShares MSCI EAFE ETF | 3.51% | 94.75 | 0.30% |
| ASML Holding NV | 1.44% | 994.22 | -0.24% |
| SAP SE | 1.40% | 274.94 | 0.99% |
| AstraZeneca PLC | 1.22% | 172.10 | 1.24% |
| Nestlé SA | 1.21% | 94.68 | 1.77% |
| Novartis AG | 1.18% | 127.10 | -1.29% |
| Roche Holding AG | 1.12% | 361.98 | -0.24% |
| HSBC Holdings Plc | 1.12% | 14.31 | 2.24% |
| Shell Plc | 1.09% | 37.05 | -0.08% |
| Siemens AG | 1.03% | 284.86 | 0.71% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP |
|
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 50000.00 None |
| Minimum Subsequent Investment | 25.00 None |
Basic Info
| Investment Strategy | |
| The investment objective of the Fund is to provide long-term growth through capital appreciation. The Fund is managed to obtain a return that approximates the performance of the MSCI EAFE Index. The MSCI EAFE Index is a free float-adjusted market capitalization index of stocks of companies of developed market equity indices covering 21 different countries in Europe, Australasia, and the Far East. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Equity |
| Global Macro | Equity Global |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | CIBC |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (10-7-25) | 1.44% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 10 |
| Stock | |
| Weighted Average PE Ratio | 23.37 |
| Weighted Average Price to Sales Ratio | 3.728 |
| Weighted Average Price to Book Ratio | 4.242 |
| Weighted Median ROE | 54.56% |
| Weighted Median ROA | 6.05% |
| ROI (TTM) | 11.48% |
| Return on Investment (TTM) | 11.48% |
| Earning Yield | 0.0568 |
| LT Debt / Shareholders Equity | 0.7487 |
| Number of Equity Holdings | 9 |
As of August 31, 2025
Growth Metrics
| EPS Growth (1Y) | 15.70% |
| EPS Growth (3Y) | 11.34% |
| EPS Growth (5Y) | 12.72% |
| Sales Growth (1Y) | 5.92% |
| Sales Growth (3Y) | 7.79% |
| Sales Growth (5Y) | 6.64% |
| Sales per Share Growth (1Y) | 7.41% |
| Sales per Share Growth (3Y) | 8.78% |
| Operating Cash Flow - Growth Rate (3Y) | 7.87% |
As of August 31, 2025
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | 12/31/2024 |
| Last Prospectus Date | -- |
| Share Classes | |
| CIB165 | Fee-based Advice |
| CIB510 | Commission-based Advice |
| CIB591 | Commission-based Advice |
| CIB778 | Commission-based Advice |
| Attributes | |
| Index Fund |
|
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:CIB317.TO", "name") |
| Broad Asset Class: =YCI("M:CIB317.TO", "broad_asset_class") |
| Broad Category: =YCI("M:CIB317.TO", "broad_category_group") |
| Prospectus Objective: =YCI("M:CIB317.TO", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |